Corient Private Wealth
BDSX icon

Corient Private Wealth’s Biodesix BDSX Stock Holding History

Corient Private Wealth’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,949
Closed -$16.6K – 2567
2025
Q2 		$16.6K Hold
2,949
– – ﹤0.01% 2412
2025
Q1 		$36.9K Hold
2,949
– – ﹤0.01% 2241
2024
Q4 		$90.2K Hold
2,949
– – ﹤0.01% 2233
2024
Q3 		$105K Hold
2,949
– – ﹤0.01% 2323
2024
Q2 		$90.2K Buy
2,949
+2,174
+281% +$62.1K ﹤0.01% 2223
2024
Q1 		$22.2K Hold
775
– – ﹤0.01% 2258
2023
Q4 		$28.5K Hold
775
– – ﹤0.01% 2219
2023
Q3 		$25.6K Hold
775
– – ﹤0.01% 2102
2023
Q2 		$19.1K Sell
775
-515
-40% -$15.4K ﹤0.01% 2052
2023
Q1 		$48K Buy
1,290
+53
+4% +$2.18K ﹤0.01% 1944
2022
Q4 		$56.9K Buy
+1,237
New +$33.6K ﹤0.01% 1616

Other funds holding BDSX

TAM
Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
MIM
Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Corient Private Wealth's BDSX Position: Q3 2025 in Review

Corient Private Wealth sold out of Biodesix (BDSX) in Q3 2025, closing a stake of 2,949 shares — an estimated $16.6K sold.

Corient Private Wealth first reported a position in BDSX in Q4 2022 and held it in 11 quarters. The position peaked at $105K in Q3 2024. 26 funds tracked by Wall St. Rank hold BDSX as of Q3 2025.

  • Corient Private Wealth reported no remaining Biodesix position as of Q3 2025 after selling out during the quarter.
  • Corient Private Wealth sold 2,949 Biodesix shares in Q3 2025, an estimated $16.6K.
  • Corient Private Wealth first reported a position in Biodesix in Q4 2022 and held it in 11 quarters.
  • Corient Private Wealth's Biodesix position peaked at $105K in Q3 2024.
  • 26 funds tracked by Wall St. Rank held Biodesix as of Q3 2025.

Based on Corient Private Wealth's 13F filing for Q3 2025, filed 14 Nov 2025.